Epidemiology of thrombocytopenia in patients with chronic hepatitis C: More than meets the eye

Journal of Viral Hepatitis

Volumn 18, Issue 1, 2011, Pages 8-10

  Giannini, E G ^a   Savarino, V ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERFERON; PEGINTERFERON; RIBAVIRIN;

ANEMIA; ARTICLE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; THROMBOCYTOPENIA;

EID: 78650277965     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01368.x     Document Type: Article

References (16)

1. Louie KS, Micallef JM, Pimenta JM, Forssen UM,. Prevalence of thrombocytopenia among chronic hepatitis C patients: a systematic review. J Viral Hep 2010; 18: 1-7.
2. Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. The American Society of Hematology ITP Practice Guideline Panel. Ann Intern Med 1997; 126: 319-326.
3. Giannini EG,. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther 2006; 23: 1055-1065.
4. Dufour JF, Pradat P, Ruivard M, et al. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases. Eur J Gastroenterol Hepatol 2009; 21: 245-253.
5. Nahon P, Ganne-Carrie N, Degos F, et al. Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis. Gastroenterol Clin Biol 2005; 29: 347-352. (Pubitemid 40646478)
6. Ivanova L, Maximov S, Kravchenko A, Tishkevich O, Ivannikov E,. The comparative analysis of morphological structure of a liver in patients with HIV-HCV coninfection and HCV-monoinfection in Russia. 16th International AIDS Conference, Toronto Canada 2006.
7. Aster RH,. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 1966; 45: 645-657.
8. Bordin G, Ballare M, Zigrossi P, et al. A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? Clin Exp Rheumatol 1995; 13 (Suppl. 13): S39-S43. (Pubitemid 26127931)
9. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M,. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24: 135-140. (Pubitemid 26059114)
10. Giannini E, Botta F, Borro P, et al. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol 2003; 98: 2516-2520. (Pubitemid 37448765)
11. Schmid M, Kreil A, Jessner W, et al. Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens. Gut 2005; 54: 1014-1020. (Pubitemid 40873919)
12. Kaushansky K,. Thrombopoietin N Engl J Med 1998; 339: 746-754. (Pubitemid 28417359)
13. Yamane A, Nakamura T, Suzuki H, et al. Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes. Blood 2008; 112: 542-550.
14. Heathcote EJ, Shiffman ML, Cooksley WGE, et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 2000; 343: 1673-1680.
15. Roomer R, Hansen BE, Janssen HL, De Knegt RJ,. Thrombocytopenia and the risk of bleeding during treatment with peginterferon alfa and ribavirin for chronic hepatitis C. J Hepatol 2010; 53: 455-459.
16. McHutchison JG, Manns M, Patel K, et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002; 123: 1061-1069.